PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
04-Jul-2024 CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe CSL Behring
03-Jul-2024 BC Platforms Announces Appointment of New Chairman, Alex Dickinson BC Platforms
03-Jul-2024 Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication Pneumagen
03-Jul-2024 Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing Syncona Limited
02-Jul-2024 Almirall launches Act4Impact – its updated sustainability strategy setting ambitious targets for 2030 Almirall
02-Jul-2024 Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 Mission Therapeutics
02-Jul-2024 ramarketing strengthens AI capabilities with key leadership appointments ramarketing
02-Jul-2024 In-Home IV Hydration Therapy Market Analysis, Size, Share, Growth, Trends Forecasts 2023-2030 Metastat Insight and Technologies Pvt. Ltd.,
01-Jul-2024 Alopecia Market Forecast 2018-2030: Comprehensive Analysis and Growth Insights Acumen Research And Consulting
01-Jul-2024 New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses Teva Pharmaceutical Industries Ltd
01-Jul-2024 Nipocalimab pivotal Phase 3 trial demonstrates sustained disease control in FcRn class for a broad population of myasthenia gravis patients Janssen-Cilag International NV
01-Jul-2024 Digital Health Market Size To Reach USD 946.0 Billion By 2030 Grand View Research, Inc.
28-Jun-2024 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma AB
28-Jun-2024 Almirall’s Ilumetri® (tildrakizumab) restores and maintains wellbeing of patients with moderate-to-severe plaque psoriasis to the levels of the general population for up to 1 year[i] Almirall
28-Jun-2024 Lindus Health Launches Bespoke “All-in-One Medical Device CRO” Offering for Medical Device Clinical Trials Lindus Health
26-Jun-2024 Mim8 demonstrated superior reductions in annualised bleeding rate (ABR) compared to on-demand and prior prophylaxis treatment in people with haemophilia A Novo Nordisk
26-Jun-2024 NICE recommends Eladynos®▼ (abaloparatide) for treating osteoporosis in postmenopausal women Theramex
26-Jun-2024 Hypopigmentation Disorder Treatment Market to Hit USD 5.2 Billion by 2032 Global Market Insights, Inc.
26-Jun-2024 Influenza Medications Market Growth: Expected to Hit USD 1.2 Billion by 2032 Global Market Insights, Inc.
26-Jun-2024 Analysis of Cell Therapy Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~21% During 2024-2036 and Attain ~USD 47.9 Billion by 2036 Research Nester